Eliseo Martínez‐García

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Satveer K. Mahil, Nick Dand, K.J. Mason et al. · Journal of Allergy and Clinical Immunology · 2020 · 158 citations · Full text

Adverse Covid-19 Outcomes, Global Health, Covid-19 Pandemic +9

Quality of life in persons living with psoriasis patients

Eliseo Martínez‐García, Salvador Arias‐Santiago, Ignacio Valenzuela-Salas et al. · Journal of the American Academy of Dermatology · 2014 · 103 citations

Quality Of Life, Life Assessment, Psoriasis Patients +4

Comparative study of the efficacy and safety of secukinumab vs ixekizumab in moderate‐to‐severe psoriasis after 1 year of treatment: Real‐world practice

Enrique Herrera‐Acosta, Gustavo Guillermo Garriga‐Martina, Jorge Alonso Suárez‐Pérez et al. · Dermatologic Therapy · 2020 · 26 citations

Week 52, Psoriatic Arthritis, Real‐world Practice +9

Vemurafenib-induced hyperkeratosis of the areola treated with topical adapelene

Eliseo Martínez‐García, Saleem Taibjee, D. Koch et al. · Clinical and Experimental Dermatology · 2015 · 11 citations

Skin Cancer, Antiparasitic Agent, Medicine +10

Ixekizumab vs ustekinumab for skin clearance in patients with moderate to severe psoriasis after a year of treatment: Real‐world practice

Enrique Herrera‐Acosta, Gustavo Guillermo Garriga‐Martina, Jorge Alonso Suárez‐Pérez et al. · Dermatologic Therapy · 2020 · 10 citations

Ixekizumab Effectiveness, Skin Clearance, Clinical Epidemiology +9